About Guizhou Yibai Pharmaceutical Company

The company was founded on June 12, 1995. It is a high-tech enterprise integrating research, development, production and sales of novel drugs. It was successfully listed on the Shanghai Stock Exchange on March 23, 2004, and became the first private enterprise listed in Guizhou Province. The main business is the pharmaceutical industry sector, the medical service sector, and the health industry sector. The company's main products include injectable loboplatin, ginkgo damole injections, anti-tumor drugs (Eddy's injection, compound cantharide capsules), cardiovascular (cardiac pulse capsules, Riki blood drop pills, Dandengtong brain drops), gynecological (gynecological inflammation capsules, Baogong hemostatic tablets, gynaecologic conditioning pills and Iwa Lu Kang tablets), pediatric products (Jinlian Heat-Clearing Effervescent Tablets), others (Golden Lotus capsules, stomach and stomach relief capsules), and family cough relief products), injectable retiplase, cobotide, medical services, candy, plant drinks, ointments, etc. Corporate honors: “China's Top 100 Pharmaceutical Manufacturing Companies”, “China's AAA Credit Enterprise”, “Guizhou Province Health Industry Outstanding Contribution Award”, “Excellent Digital Transformation Practice Unit in Western China”, “Excellent Brand Enterprise of the Year”, “Guizhou Top 100 Private Enterprises”, “Guizhou Top 100 Private Enterprises”, “Guizhou Top 100 Manufacturing Enterprises”, “Top 100 Chinese National Pharmaceutical Brand Enterprises”, “China's Top 500 Chinese Pharmaceutical Industry Credit Enterprises”, “Top 20 Private Enterprises in Guizhou Province””, Awards and honors such as “Best Industrial Enterprise in China's Pharmaceutical R&D Industry Line”.